Accepted for/Published in: JMIR Infodemiology
Date Submitted: Oct 25, 2025
Date Accepted: Mar 2, 2026
The Information Void in Asymptomatic Chronic Disease: A Digital Health Framework for Understanding Social Media Health Information-Seeking in Young Adults
ABSTRACT
Nearly one in four young adults has a chronic condition, yet many feel well despite their diagnosis. Asymptomatic conditions like prediabetes and hypertension create a unique vulnerability to digital health misinformation, particularly on platforms where inaccurate content is prevalent. Conventional clinical responses, which often just warn patients about online misinformation, fail to address the underlying drivers of this behavior. This viewpoint proposes a novel disease characteristic-based vulnerability framework to understand this challenge. We identify an "information void" for asymptomatic conditions managed primarily by lifestyle modification. This void, created by the absence of symptomatic feedback combined with delayed clinical biomarker feedback, compels patients to seek information online. Instead of viewing this information-seeking as a problematic deviation, we reframe it as a "digital phenotype" indicating a patient's readiness for behavior change. A constructive response requires moving beyond simple warnings. Evidence supports a multi-pronged approach: integrating digital health literacy into clinical encounters, providing curated evidence-based resources, and pursuing strategic institutional engagement in digital spaces. This framework offers a generalizable strategy for engaging with patients' information needs, transforming a public health challenge into an opportunity for empowerment.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.